|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Partneringdesk Ono Pharmaceutical Co., Ltd. and Company Deals Briefing |
|
|
|
|
€ 340,00 |
Editeur
: |
Bridgehead |
Langue
: |
Anglais |
Date de publication : |
Juin 2006 |
Taille du document : |
46 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 67 pages | Janvier 2005 | Anglais
|
|
|
| Main
focus: |
financials
|
| Research
focus: |
market definition,competition analysis |
| Geographic
focus: |
usa |
| |
|
|
|
|
| 45 pages | Avril 2004 | Anglais
|
|
|
| Main
focus: |
financials,financial analytics,wifi
|
| Research
focus: |
competition analysis,industry structure, |
| Geographic
focus: |
usa,france,united kingdom,germany |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
3 500,00 €
|
| |
| |
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
1 200,00 €
|
|
| |
| |
Antisense Therapy: Technical Aspects and Commercial Opportunities
334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process.
Besides the well known oligonucleotides ( |
955,00 €
|
| |
| |
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
173 pages | Mars 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once near unrestricted revenue expansion existed, external pressures now act in unison |
955,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval
113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs
119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike.
A great need exists for ph |
795,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Pfizer's Recent Takeover
15 pages | Juillet 2002 |
On 15th July 2002, Pfizer announced the acquisition of Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care.
|
300,00 €
|
| |
| |
Top Ten and Emerging Pharmaceutical markets
214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals.
Mar |
795,00 €
|
| |
| |
The Pharmaceutical Mergers and Acquisitions Outlook 2001
128 pages | Octobre 2001 |
Pharmaceutical companies have recently undertaken extensive M&A activity to either build critical mass, create organic growth or through strategic alliances to build virtual mass.
The Pharmaceu |
1 200,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Partneringdesk Ono Pharmaceutical Co., Ltd. and Company Deals Briefing |
|
|
A Partneringdesk Deals Briefing provides an in-depth view of all the deals made by the company and its subsidiaries between 2001 and 2006, in a clear and accessible PDF format.
Chapter 1: Company profile
An overview of the company, including contact details, and expertise in terms of industry sector, therapy focus and management.
Chapter 2: Financial data and deals overview
A summary of the company’s financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.
Chapter 3: Summary of deals
A comprehensive overview listing deals by partner company, subsidiary, therapy focus, development stage, deal type and industry sector with a full index of all the deals announced.
Chapter 4: List of deals
A detailed listing of all the company’s deals and alliances announced between January 2001 and March 2006.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments where disclosed.
|
|
Introduction
About Partneringdesk Deals Briefings
Chapter 1: Company profile
Chapter 2: Financial data and deals overview
Chapter 3: Summary of deals
Company deals categorized by partner company
Company deals categorized by subsidiary
Company deals categorized by therapy focus
Company deals categorized by development stage
Company deals categorized by deal type
Company deals categorized by industry sector
Chapter 4: List of deals
Glossary
Table 2.1 Company financial summary
Table 2.2 Company deals by deal type
Table 2.3 Company deals by therapy focus
Table 2.4 Company deals by development stage
Table 2.5 Company deals by industry sector
|
|
|
PPLSEN
|
|
|
|
|
